Revenue Cycle Management Market worth $67.8 billion by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Revenue Cycle Management/RCM Market by Product & Services (Eligibility Verification, Clinical Coding, CDI, Claims Processing, Denial Management, Outsourcing Services, Cloud), End User(Payers, Hospitals, Outpatient), Covid-19 Impact - Global Forecast to 2026", published by MarketsandMarkets™, the global RCM Market is projected to reach USD 67.8 billion by 2026 from USD 40.9 billion in 2021, at a CAGR of 10.6% during the forecast period.

Browse in-depth TOC on "Revenue Cycle Management Market"

242 – Tables
40 – Figures
286 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153900104

The growth of this market is majorly attributed to the need for increasing patient volumes, and the growing need to manage unstructured healthcare data. Also, growing regulatory requirements & government initiatives are expected to drive demand growth in the IoT medical devices market during the forecast period.

By product & services, segment the outsourcing services segment is expected to grow at the highest growth rate during the forecast period

Among the product & services, the outsourcing services segment is expected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the lack of IT infrastructure and the shortage of skilled HCIT personnel.

By delivery mode, the on-premise segment is expected to account for the largest share of the revenue cycle management market

The on-premise segment accounted for the largest share of the global RCM Market in 2020. The large share of this segment is attributed to the increasing demand for mobile support systems for better customer (patient) engagement platforms.

By end user, the healthcare providers segment is expected to account for the largest share of the RCM Market

Based on end user, the revenue cycle management market is segmented into healthcare providers and healthcare payers. Revenue cycle management solutions help healthcare providers automate the process from patient registration to billing and claims processing and provide better transparency that improves the overall financial health of the provider organization. This is a major factor driving the growth of this segment.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=153900104

North America dominates the revenue cycle management market during the forecast period.

North America accounted for the largest share of the RCM Market in 2020. The large share of this region can be attributed to factors such as stringent regulations, increasing volume of claims denials, the presence of a high number of private healthcare payers and well-established government payers, and a large number of healthcare IT companies are some of the factors driving the growth of the revenue cycle management market in this region.

R1 RCM (US), Cerner Corporation (US), Optum (US) are the leading players in the market. Other players include McKesson Corporation (US), Change Healthcare (US), 3M (US), Experian plc (Ireland), Conifer Health Solutions (US), Allscripts Healthcare Solutions (US), GE Healthcare (US), Cognizant (US), athenahealth (US), SSI Group LLC (US), AdvantEdge Healthcare (US), and Huron Consulting Group (US)

Browse Related Reports:

Healthcare EDI Market by Component (Solution, Service), Delivery Mode (On-premise & Cloud, Mobile) Transaction Type (Claims Management, Payment Remittance, Payments, Healthcare Supply Chain), End-User - Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/healthcare-edi-market-130571438.html

Healthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantics), End User and Region - Global Forecast to 2026

https://www.marketsandmarkets.com/Market-Reports/healthcare-interoperability-solution-market-17705847.html

 

Surgical Robots Market worth $14.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Surgical Robots Market by Product & Service (Instruments & Accessories, Systems, Service), Application (Urological Surgery, Gynecological Surgery, Orthopedic Surgery), End User (Hospitals, Ambulatory Surgery Center) - Analysis and Global Forecasts to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 14.4 billion by 2026 from an estimated USD 6.4 billion in 2021, at a CAGR of 17.6%.

Browse in-depth TOC on "Surgical Robots Market"
212 – Tables
35 – Figures
220 – Pages

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

The Growth in this market is primarily driven by the advantages of robotic-assisted surgery, technological advancements in surgical robots, the increasing adoption of surgical robots, and increased funding for medical robot research. The companies have a large market spread across various countries in North America, Europe, Asia Pacific, and the Rest of the World.

The COVID-19 pandemic has had a devastating global impact on the world's population and economy. The pandemic has put a significant strain on healthcare systems. During this period, healthcare institutions and providers have been instructed to stop performing elective surgical procedures and medical examinations to minimize the possibility of transmission and conserve healthcare resources for COVID-19 patients. The pandemic has led to a temporary ban on elective surgeries across the globe, which resulted in the cancellations of elective surgeries worldwide posing a negative impact on the globe.

Instruments and Accessories to account for the largest share in the market

Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services. The instruments & accessories segment commanded the largest share of 53.8% of the market in 2020. This segment is also expected to grow at the highest CAGR of 18.2% during the forecast period. The large share and high growth rate of this segment are mainly driven by the recurrent purchase of instruments & accessories instead of robotic systems, which are a one-time investment.

General surgery to account for the fastest growing application in the market

Based on application, the surgical robots market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications. The general surgery segment commanded the largest share of 29.5% of the market in 2020. This segment is also projected to register the highest CAGR of 18.2% during the forecast period. Growth in this market segment can be attributed to the increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532

Asia Pacific to Witness highest growth from 2021 to 2026

North America dominated the surgical robots market, with a share of 63.6% in 2019, while the Asia Pacific region is expected to register the highest CAGR of 18.5% during the forecast period. The large share of the North American market can be attributed to the availability of funding for R&D in surgical robots in this region and the increasing adoption of surgical robots for pediatric surgeries in Canada and general surgery procedures in the US.

Some of the prominent players operating in the Surgical robots market are Intuitive Surgical (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (Transenterix) (US), Corindus Vascular Robotics (US), Renishaw (UK), Auris Health (US), Medrobotics Corporation (US), Think Surgical (US), Verb Surgical (US), OMNIlife Science (US), CMR  Surgical (US), Preceyes BV (Netherlands), China National Scientific Instruments And Materials Corporation (CSIMC) (China), Microsure (Netherlands), Titan Medical (Canada), avateramedical Gmbh (Germany) and Medicaroid Corporation (Japan).

 

 

Ventilators Market worth $1.9 billion in 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Ventilators Market by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hospital, Clinic, Home Care, ACC, Emergency Medical Services), Region - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 1.9 billion in 2026 from USD 1.4 billion in 2021, at a CAGR of 7.6% during the forecast period.

Browse and in-depth TOC on "Ventilators Market"
212 - Tables
61 - Figures
267 - Pages

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337

A ventilator, breathing machine, or respirator is a machine that assists with breathing. It is mainly used in hospitals to treat chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung injury, and hypoxemia. Over the years, the Ventilators Market has evolved significantly due to technological advancements, such as developing advanced portable ventilators and improvements in the sensor technologies used in ventilators. The increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, rising number of ICU beds, and rising number of COVID-19 patients are expected to drive growth in the market during the forecast period. The emergence of home healthcare has opened new avenues for the ventilator market. Convenience and comfort in the home care environment, coupled with cost advantages, are the other major factors driving growth in the home healthcare market for ventilators.

By mobility, the intensive care segment is expected to account for the largest share of the Ventilators Market

The intensive care segment accounted for the largest share of the global ventilator market in 2020. The large share of the intensive care ventilators segment can be attributed to the rising number of intensive care beds equipped with ventilators. Increasing ICU admissions due to COVID-19 and re-admissions in developed countries, coupled with appropriate reimbursements, are also responsible for the large share of the ICU ventilators segment.

On the basis of type, adult/pediatric ventilators segment is expected to account for the largest share of the Ventilators Market

Based on type, the ventilator market is segmented into adult/pediatric ventilators segment and neonatal/infant ventilators. The adult/pediatric ventilators segment accounted for the largest share of the market in 2020. The large share of the adult/pediatric ventilators segment can be attributed to the large adult population suffering from COVID-19, the growing incidence of chronic diseases such as COPD & asthma, the growing number of smokers, and the rising geriatric population.

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=11018337

On the basis of interface, invasive ventilation segment is expected to account for the largest share of the Ventilators Market

Based on interface, the invasive ventilation segment accounted for the largest share of the Ventilators Market in 2020. Growth in the invasive ventilation market can be attributed to the increasing severity in COVID-19 patients and the rising prevalence of respiratory diseases, neurological diseases, and sleeping disorders.

On the basis of mode, the combined-mode ventilation segment is expected to account for the largest share of the Ventilators Market        

Based on mode, the combined-mode ventilation segment accounted for the largest share of the market in 2020. The large share of this segment can be attributed to its advantages over conventional pressure-mode ventilation and volume-mode ventilation. The ability of combined-mode ventilation to provide both modes of ventilation makes it a desirable product in the market.

On the basis of end user, hospitals & clinics segment holds the highest market share in the Ventilators Market

Based on end user, the hospitals & clinics segment is likely to dominate the ventilator market during the forecast period is attributed to the financial capabilities of hospitals to purchase high-priced instruments and the availability of trained professionals to operate ventilators. Market growth is also driven by the rapidly increasing incidence of coronavirus disease. The COVID-19 outbreak has not only created pressure on healthcare resources but has also increased the number of hospital admissions.

Speak to Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=11018337

North America to dominate the Ventilators Market during the forecast period

The ventilator market in North America dominated the market in the forecast period. The rising geriatric population, growing number of smokers, high prevalence of respiratory diseases, increasing COVID-19 patient volumes, highly developed healthcare system, high healthcare expenditure, and major market players in the US are the key factors driving the market in North America.

Prominent players in the Ventilators Market include Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK) and Allied Healthcare Products, Inc. (US).

 

Veterinary Imaging Market worth $2.3 billion by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Veterinary Imaging Market by Product (Ultrasound (2D, 3D, Doppler), X-Ray (CR, DR), MRI, CT, Software, Reagent), Therapeutic Area (Orthopedics, Gynecology, Oncology, Dentistry), Animal (Small, Large), End User (Hospital, Clinic) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 2.3 billion by 2026 from USD 1.6 billion in 2021, growing at a CAGR of 7.0% during the forecast period.

The growth of the global veterinary imaging market during the forecast period is mainly driven by the increasing rate of companion animal population, rising demand for pet insurance and an increasing amount of animal health expenditure, growing number of veterinary practitioners and their rising income levels in developed economies, rising demand for animal-derived food products, and growing prevalence of animal diseases. Emerging markets, such as India and China, and growing companion animal ownership in the APAC region are also factors expected to offer significant growth opportunities for players in the market. On the other hand, lack of animal healthcare awareness, a severe shortage of skilled veterinarians, and the high cost of imaging instruments in emerging countries are factors expected to restrain the overall market growth, to a certain extent, during the forecast period.

Browse in-depth TOC on "Veterinary Imaging Market"
331 – Tables
63 – Figures
371 – Pages

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80889726

The impact of the COVID-19 pandemic and the lockdowns it triggered is clearly visible on various markets, including the veterinary imaging market. In 2020 and early 2021, the overall growth of various sectors was heavily impacted, specifically in countries with a high incidence rate of COVID-19, such as India, Brazil, China, the US, and several European countries (including Russia, Italy, the UK, and Spain).

The COVID-19 pandemic is expected to have a temporary negative impact on the market or its growth during the forecast period. The outbreak of COVID-19 originated from a meat market in Wuhan (China), which has negatively affected the consumption of food products derived from animal sources. Unfavorable changes in regulations and guidelines are hampering the growth of this market. The closing down of manufacturing facilities due to lockdowns, disruptions in supply chains, and recruitment challenges for clinical trials have further impacted the growth of the overall veterinary imaging market. Furthermore, trade barriers in various regions are also expected to restrain the growth of the market.

The Veterinary Imaging Instruments segment holds the largest market share during the forecast period.

On the basis of products, the global market is segmented into veterinary imaging instruments, reagents, and software. In 2020, the instruments segment accounted for the largest share of the global veterinary imaging market. Growth in this product segment can largely be attributed to the increasing adoption of digital imaging owing to the high-quality images provided by these instruments for disease diagnosis.

Request Sample Pages:-

 https://www.marketsandmarkets.com/requestsampleNew.asp?id=80889726

In the therapeutic area segment, Orthopedics & Traumatology segment holds the largest market share during the forecast period

Based on the type of therapeutic area, the market is segmented into cardiology, neurology, oncology, orthopedics & traumatology, dentistry, obstetrics & gynecology, and other therapeutic areas, which include veterinary ophthalmology and nephrology. In 2020, the orthopedics and traumatology segment accounted for the largest share of the global veterinary imaging market. The largest share of this segment can be attributed to the growing incidence of bone injuries and the increasing prevalence of arthritis, lameness diseases, and joint disorders in animals.

In the animal type segment, small companion animals segment is expected to grow at the largest share in the veterinary imaging market

Based on the type of animal, the market is segmented into small companion animals, large animals, and other animals. The small companion animals segment accounted for the largest market share in 2020. This can be attributed to the increasing adoption of companion pets, increasing focus on the safety of companion animals, growing expenditure on animal health and preventative care, increasing demand for pet insurance, aging pet population, and growing technological advancements in imaging modalities. The small companion animals segment is also expected to register the highest growth during the forecast period.

In the end user segment, Veterinary Clinics & Diagnostic Centers segment is expected to account for the largest share in the veterinary imaging market

On the basis of end users, the global market is segmented into veterinary clinics and diagnostic centers and veterinary hospitals and academic institutions. Veterinary clinics and diagnostic centers are the major end users in the market and accounted for a share in 2020. The large share of this segment is primarily attributed to the increasing number of veterinary practices and the growing number of veterinarians.

APAC is expected to grow at the highest growth rate in 2020

The Asia Pacific region is expected to register the highest CAGR during the forecast period. Growing pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China, are contributing to the growth of the APAC market.

Key players in the veterinary imaging market

The prominent players in the market are GE Healthcare (US), Agfa-Gevaert N.V. (Belgium), Carestream Health (US), Esaote S.p.A (Italy), IDEXX Laboratories, Inc. (US), Mindray Medical International Limited (China), Canon Inc. (Japan), Heska Corporation (US), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Konica Minolta Inc. (Japan), Samsung Electronics Co., Ltd. (South Korea), E.I. Medical Imaging (US), IMV imaging (UK), SEDECAL (Spain). Other players in the veterinary imaging market are Clarius Mobile Health (Canada), Shenzhen Ricso Technology Co. Ltd. (China), DRAMIÑSKI S.A. (Poland), Epica Animal Health (US), and ClearVet Digital Radiography Systems (US), MinXray Inc. (US), Hallmarq Veterinary Imaging (UK), Shantou Institute of Ultrasonic Instruments Co., Ltd (China), Sonoscape Medical Corp. (China), and Reproscan (US).

 

Wearable Injectors Market worth $11.5 billion by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Wearable Injectors Market by Product Type(On-Body and Off-Body), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases), Technology(Spring-based, Motor Driven, Rotary Pump, Expanding Battery), Care Setting (Hospitals) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 11.5 billion by 2026 from USD 7.2 billion in 2021, at a CAGR of 9.9% during the forecast period.

Browse in-depth TOC on "Wearable Injectors Market"
114 – Tables
51 – Figures
196 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004

The Growth in this market is mainly driven by factors such as the shift of healthcare delivery toward homecare due to COVID-19, advantages of wearable injectors in the administration of various drugs, the rising prevalence of chronic diseases (such as cancer, diabetes, and CVD), favorable reimbursement scenario in major markets, and technological advancements in injector devices. However, the preference for alternative drug delivery modes, high costs, and a poor reimbursement structure in developing countries are expected to limit the adoption of wearable injectors to a certain extent.

By Type, the on-body injectors segment is expected to account for the largest share of the wearable injectors market

By type, the global market is segmented into on-body injectors and off-body injectors. The on-body injectors segment accounted for the largest share in the forecast year. The large share of this segment can be attributed to the patients ease to deliver a precise amount of drug to the body over a controlled period of time.

On the basis of technology, spring based segment is expected to account for the largest share of the market

Based on technology, the wearable injectors market is segmented into spring-based, motor-driven, rotary pump, expanding battery, and other technologies. The spring-based technology segment accounted for the largest share in the forecast period. The large share of this segment can be attributed to the rising demand for adhesive patches, as these devices are user-friendly and enable patients to accurately deliver the required drug subcutaneously.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=100771004

On the basis of therapy, diabetes segment is expected to account for the largest share of the market

Based on therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (such as Parkinson's disease, thalassemia, and primary immunodeficiency disorders). The diabetes segment accounted for the largest share in the forecast period. The large share of this segment can be attributed to The high burden of diabetes across the globe, coupled with the growing availability of wearable injectors for the treatment of these diseases, is driving the growth of this market segment.

On the basis of end user, hospitals and clinics segment holds the highest market share in the wearable injectors market

Based on end user, the market is segmented into hospitals and clinics and home healthcare settings. The hospitals and clinics segment accounted for a larger market share during the forecast period. The large share of this segment can primarily be attributed to the rising preference for the self-administration of medication and the increasing need to curb healthcare costs. In addition, the growing demand for technologically developed drug delivery approaches, which lower the hospitalization rate and require minimal expertise, is expected to boost the growth of the home healthcare settings segment.

Speak to Analyst :-https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=100771004

North America to dominate the wearable injectors market during the forecast period

The wearable injector market in North America accounted for the largest market during the forecast period. The large share of North America in this market is to the rising prevalence of chronic and lifestyle-related diseases and the presence of advanced healthcare infrastructure in the region. However, the Europe market is estimated to grow at the highest CAGR during the forecast period owing to factors such as the Increasing prevalence of chronic diseases, Government support for drug development in Germany, Rising focus on biosimilar innovation in the UK, Favorable reimbursement scenario for various treatment options in France.

Prominent players in the wearable injectors market include Becton, Dickinson and Company(US), Ypsomed(Switzerland), Amgen(US), Subcuject(Denmark), Enable Injections, Inc(US), Medtronic Plc(Ireland), Insulet Corporation(US), United Therapeutics Corp (Us), CeQur SA(Switzerland), Sensile Medical(Switzerland).

Browse Related Reports:

Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/insulin-delivery-device-market-107632092.html

 

Albumin & Creatinine Tests Market worth $2,103 million by 2025 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025", published by MarketsandMarkets™, the ACR Test Market is projected to reach USD 2,103 million by 2025 from USD 987 million in 2020, at a CAGR of 16.3%.

Browse in-depth TOC on "Albumin and Creatinine Tests Market"
131 – Tables
32 – Figures
159 – Pages

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156696568

  The growth of the global albumin & creatinine tests market is driven by factors such as the growing prevalence of kidney disorders, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions.

The dipsticks & kits products segment accounted for the largest share of the ACR Tests Market, by product segment, in 2019

Based on product, the albumin and creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables. In 2019, the dipsticks & kits segment accounted for the largest share in this market. The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth.

Urine Tests segment to register the highest growth rate during the forecast period

Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests. In 2019, urine tests accounted for the largest share in this market. Factors such as the rapid growth in the diagnostics segment and the increasing demand for rapid and easy-to-use urine tests drive the growth of this segment.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: -  https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=156696568

North America is the largest regional market for albumin & creatinine tests market

The global ACR Test Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share in the global market. The large share of this regional segment can primarily be attributed to the growth in demand for rapid urine tests, increasing prevalence of chronic conditions leading to various kidney diseases, rising government initiatives, and growing geriatric population.

The major players operating in this ACR Tests Market are Thermo Fisher Scientific, Inc. (US), Roche Diagnostics (Switzerland), PromoCell GmbH (Germany), Abbott Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Randox Laboratories (UK), FUJIFILM Wako Pure Chemical Corporation (Japan), Abbexa Ltd. (UK), ACON Laboratories, Inc. (US), Arbor Assays Inc. (US), ARKRAY Global Business Inc. (Japan), Aviva Systems Biology (US), Axxora, LLC (UK), BioAssay Systems (US), Nova Biomedical (US), Quantimetrix Corporation (US), RayBiotech Inc. (US), Sekisui Diagnostics PEI Inc. (US), Teco Diagnostics (US), Tulip Diagnostics (India), ulti med Products GmbH (Germany), and URIT Medical Electronic Co., Ltd. (China).

Browse Related Reports:

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024
https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html